12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Dicerna Pharmaceuticals DRNA stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is at $2.9 billion.
  • Cardiff Oncology CRDF shares moved upwards by 21.41% to $6.35. The market value of their outstanding shares is at $251.1 million.
  • PetVivo Holdings PETV shares moved upwards by 14.55% to $3.7. The market value of their outstanding shares is at $35.6 million. As per the press release, Q2 earnings came out 3 days ago.
  • Arcus Biosciences RCUS stock moved upwards by 14.46% to $42.25. The market value of their outstanding shares is at $2.9 billion.
  • Pasithea Therapeutics KTTA stock rose 10.5% to $2.63. The market value of their outstanding shares is at $34.3 million.
  • Calithera Biosciences CALA stock moved upwards by 10.35% to $1.01. The company's market cap stands at $75.6 million.
  •  

Losers

  • Certara CERT shares fell 11.14% to $32.0 during Thursday's pre-market session. The company's market cap stands at $5.1 billion.
  • Nutriband NTRB shares decreased by 6.99% to $5.73. The market value of their outstanding shares is at $42.4 million.
  • Eloxx Pharmaceuticals ELOX stock fell 6.69% to $0.81. The market value of their outstanding shares is at $69.8 million.
  • Rockwell Medical RMTI shares fell 6.48% to $0.51. The company's market cap stands at $47.9 million. As per the press release, Q3 earnings came out 3 days ago.
  • Molecular Partners MOLN stock decreased by 6.01% to $9.87. The market value of their outstanding shares is at $318.6 million.
  • Freeline Therapeutics FRLN stock declined by 5.19% to $2.56. The market value of their outstanding shares is at $91.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!